Welcome to our dedicated page for Ryan Specialty Hldgs SEC filings (Ticker: RYAN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ryan Specialty Holdings, Inc. (NYSE: RYAN) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Ryan Specialty is an international specialty insurance firm that serves insurance brokers, agents, and carriers through distribution, underwriting, product development, administration, and risk management services, and its filings offer detailed insight into how this business is structured and performs.
Investors can review current reports on Form 8-K, where Ryan Specialty discloses material events. Recent 8-K filings have covered topics such as quarterly financial results and the associated earnings press releases, regular quarterly dividends on Class A common stock, appointments and retirements of directors, and changes in executive roles, including the appointment of Co-Presidents and related governance matters. These filings often incorporate press releases by reference, providing context for operational and governance decisions.
In addition to 8-Ks, users can access Ryan Specialty’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which contain comprehensive financial statements, segment information for specialties such as Wholesale Brokerage, Binding Authority, and Underwriting Management, and discussions of non-GAAP measures like Organic Revenue Growth Rate, Adjusted EBITDAC, and Adjusted net income. These documents also include risk factor discussions and other disclosures relevant to the specialty insurance business.
Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, helping readers understand revenue composition, expense ratios, non-GAAP metrics, and governance changes without reading every page. The platform updates in near real time as new RYAN filings are posted to EDGAR, and also surfaces information related to dividends and board decisions. For users researching RYAN stock, this filings hub offers a structured way to analyze Ryan Specialty’s regulatory history and ongoing reporting obligations.
Ryan Specialty Holdings files its annual report describing a fast-growing specialty insurance intermediary focused on the excess and surplus (E&S) market. For 2025, revenue rose 21.3%, driven by Wholesale Brokerage, Binding Authority, and Underwriting Management operations.
Wholesale Brokerage generated $1,600.4 million in net commissions and fees, Binding Authority $370.2 million, and Underwriting Management $1,024.0 million. Diluted earnings per share were $0.47 versus $0.71 in 2024, while Adjusted diluted EPS increased from $1.79 to $1.96, reflecting strong underlying performance despite higher investments and non‑GAAP adjustments.
The company emphasizes its leadership in the E&S market, where 78% of 2025 premiums were placed, and highlights consolidation among retail brokers and carriers as a tailwind. It reports strategic acquisitions in 2025, expanded international MGAs/MGUs, and ongoing investments in technology, including generative AI and the RT Connector digital marketplace, to support scalability and innovation.
Ryan Specialty Holdings reported strong 2025 growth but softer profitability, and announced several major capital actions. Full-year 2025 revenue rose 21.3% to $3.05 billion, with organic revenue growth of 10.1%. Adjusted EBITDAC increased 19.2% to $966.7 million, while net income declined 6.9% to $214.2 million.
In the fourth quarter, revenue grew 13.2% to $751.2 million, but net income fell 26.6% to $31.2 million as operating expenses and interest costs increased, compressing net income margin to 4.2%. Adjusted EBITDAC for the quarter rose 2.9% to $222.3 million, and adjusted diluted EPS held flat at $0.45.
The board approved a three-year “Empower Program” restructuring, expected to incur about $160 million of pre-tax charges through 2028 and generate roughly $80 million of annual savings in 2029. The board also authorized a share repurchase program of up to $300 million of Class A stock and raised the regular quarterly dividend by 8.3% to $0.13 per share, payable March 10, 2026 to holders of record on February 24, 2026.
Ryan Specialty Holdings, Inc. has scheduled its 2026 annual meeting of stockholders for April 28, 2026, to be held virtually by remote communication. Stockholders of record at the close of business on March 2, 2026 will be entitled to receive notice of and vote at the meeting.
The company set a February 22, 2026 deadline for stockholder proposals seeking inclusion in its proxy materials under SEC Rule 14a-8. For other proposals or director nominations under the company’s bylaws, written notice must be received by February 20, 2026 and comply with the bylaw and Rule 14a-19 requirements.
Ryan Specialty Holdings, Inc.’s chief executive officer and director reported an exchange of incentive units and a related stock sale. On 12/11/2025, Class C Common Incentive Units in New Ryan Specialty, LLC were exchanged into 129,964 shares of Class A Common Stock under the LLC operating agreement. On 12/12/2025, 129,570 Class A shares were sold in a block trade at $53.61 per share to satisfy a separation of assets obligation under the reporting person’s divorce settlement.
After these transactions, the insider beneficially owned 12,553 shares of Class A Common Stock directly and 165,942 Class C Common Incentive Units, which may be exchangeable into Common Units and then into Class A shares based on a return threshold that is currently $23.14 per unit.
Ryan Specialty Holdings (RYAN) received a notice that a shareholder plans to sell up to 129,570 shares of its Class A common stock under Rule 144. The planned sale is to be executed through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $7,016,215 based on the pricing used in the notice. The filing states that 128,776,025 shares of Class A common stock were outstanding, providing context for the size of the proposed sale. The securities were originally acquired on 07/22/2021 through a conversion of pre-IPO incentive equity into LLC units of the post-IPO up-C corporate structure.
Ryan Specialty Holdings director filed a Form 4 reporting a transfer of 2,100 shares of Class A common stock on 12/10/2025. The transaction, coded "G," moved shares at a reported price of $0 per share into trusts for which he serves as trustee and that benefit him and/or family members. After this activity, he beneficially owns 402,795 shares indirectly through the trusts and 256,194.053 shares directly. He states that he disclaims beneficial ownership of the trust-held shares except to the extent of his pecuniary interest in them.
Ryan Specialty Holdings insider Patrick G. Ryan reported a gift of 2,100 shares of Class A common stock on December 10, 2025. The shares were transferred at a price of $0 from insider living trusts where he and his spouse serve as co-trustees, with the gift made equally from each trust. After this transaction, he indirectly holds 13,697,859 Class A shares through these insider living trusts and an additional 55,475 Class A shares held in other trusts and entities for the benefit of a family member. Ryan is listed as a director, 10% owner, and Executive Chairman of the company, and this filing reflects an update to his indirect beneficial ownership.
Ryan Specialty Holdings, Inc. reported that Robert Le Blanc will retire from its Board of Directors effective February 11, 2026. His service on the Compensation and Governance Committee will also end on that date. The company states that his decision to retire is not the result of any disagreement with the company, which signals an orderly and planned transition rather than a dispute-driven departure.
Ryan Specialty expressed gratitude for Mr. Le Blanc’s many years of service and contributions to the Board. On December 8, 2025, the company issued a press release to publicly announce his retirement, which is furnished as an exhibit to this report.
Ryan Specialty Holdings, Inc. (RYAN) reported a large insider sale by a group of reporting persons associated with Onex. On 12/05/2025, they reported the sale of 4,145,621 shares of Class A common stock at a price of $54.5 per share, coded as an open-market or private sale ("S").
After this transaction, the reporting persons show 0 shares of Class A common stock beneficially owned. The filing explains that Onex Corporation controls the entities that previously held the shares and that certain parties, including Onex Corporation and its chairman, disclaim beneficial ownership except for their pecuniary interests. It also notes that, because an Onex executive serves on Ryan Specialty’s board, each reporting person may be considered a director by deputization.
Ryan Specialty Holdings, Inc. had a holder file a notice of intent to sell Class A common stock under Rule 144. The planned sale covers 173,778 shares through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $9,757,634.70 based on the figures provided. The filing notes that 128,776,025 shares of this class were outstanding at the time of the notice, giving context for the size of the proposed sale.
The seller originally acquired 522,119 shares on 07/22/2021 in exchange transactions completed in connection with the company’s IPO, receiving the stock in exchange for interests in a pre-IPO predecessor. By signing the notice, the seller represents that they are not aware of undisclosed material adverse information about the company’s operations.